Concepedia

Diana G. Wang

DG

Statistics

Publications

7

Citations

1.2K

H-Index

7

Active since

2013

Affiliations

Cornell University(Current)

Memorial Sloan Kettering Cancer Center

Weill Cornell Medicine

Tri-Institutional PhD Program in Chemical Biology

Presbyterian Hospital

Diana G. Wang is an author at Cornell University specializing in medicine, oncology, and signal transduction.

ORCID

Publications per year

2013–2020

7

Publications

7

Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

Benjamin D. Hopkins, Chantal Pauli, Xing Du et al. · Nature · 2018 · 713 citations · Full text

, , +14

Nkx2-1 Represses a Latent Gastric Differentiation Program in Lung Adenocarcinoma

Eric L. Snyder, Hideo Watanabe, Margaret Magendantz et al. · Molecular Cell · 2013 · 283 citations · Full text

, , +14

PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism

Diana G. Wang, Marcia N. Paddock, Mark R. Lundquist et al. · Cell Reports · 2019 · 64 citations · Full text

, , +17

Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors

Sindhu Carmen Sivakumaren, Hyeseok Shim, Tinghu Zhang et al. · Cell chemical biology · 2020 · 56 citations · Full text

, , +14

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer

Diana G. Wang, Dulce M. Barrios, Victoria Blinder et al. · Breast Cancer Research and Treatment · 2020 · 37 citations · Full text

, , +14

1–5 of 7